Simtra BioPharma Solutions partners with pharmaceutical and biotech companies to support their commercialization objectives by providing scientific expertise, sterile contract manufacturing solutions, and customized support services needed to meet the unique challenges that parenteral products face.
FEATURED CONTENT
CONTACT INFORMATION
Simtra BioPharma Solutions
927 S Curry Pike
Bloomington, IN 47403
UNITED STATES
Contact: Jennifer Wendorf
FEATURED BROCHURES
FEATURED VIDEOS
NEWS
- Simtra BioPharma Solutions Expands Global Manufacturing Footprint To Advance The Future Of Sterile Injectables
- Simtra BioPharma Solutions Announces Strategic Purchase To Expand U.S. Manufacturing Capacity For Injectable Medicines
- Simtra BioPharma Solutions Expands Halle/Westfalen, Germany Facility With The Addition Of A New Production Building
- Simtra BioPharma Solutions And MilliporeSigma Announce Strategic Alliance For Antibody Drug Conjugates Drug Substance And Drug Product Manufacturing Services
- Simtra BioPharma Solutions Releases First Sustainability Report, Underscoring Commitment To Responsible Growth
- Simtra BioPharma Solutions Expands Capabilities With $14M Investment In ADC Conjugation And Purification Clinical Suite
- Simtra BioPharma Solutions Appoints Dr. Mike Schäfers As Chief Commercial Officer
- Simtra BioPharma Solutions Appoints Dr. Lidia Serina As Head Of Development Services
- Simtra BioPharma Solutions Announces $250+M Investment To Expand Sterile Fill/Finish Manufacturing Site In Bloomington, Indiana
- Simtra BioPharma Solutions Unveils New Corporate Headquarters In Parsippany, New Jersey
- Baxter Signs Definitive Agreement To Divest Its BioPharma Solutions Business To Advent International And Warburg Pincus For $4.25 Billion
- Baxter Announces $100 Million Investment In BioPharma Solutions Halle/Westfalen, Germany Sterile Fill/Finish Manufacturing Facility